asthma medication

CSL is setting its sights on the US$21.6 billion (AU$33.54 billion) asthma market with the development of a groundbreaking drug designed to combat a lung inflammation that primarily triggers the ...

Australian asthma suffers will now be able to avoid running out of Ventolin when they most desperately need ...